Citalopram in refractory obsessive - Compulsive disorder: An open study

International Clinical Psychopharmacology

Volumn 16, Issue 4, 2001, Pages 215-219

  Marazziti, D ^a   Dell'Osso, L ^a   Gemignani, A ^a   Ciapparelli, A ^a   Presta, S ^a   Di Nasso, E ^a   Pfanner, C ^a   Cassano, G B ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Augmentation strategies; Citalopram; Obsessive compulsive disorder; Serotonin reuptake inhibitors

Indexed keywords

CITALOPRAM; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; FEMALE; HUMAN; MALE; NAUSEA; OBSESSION; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; TREATMENT OUTCOME;

EID: 0034957597     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200107000-00005     Document Type: Article

References (33)

1. Treating the treatment-resistant patients
2. Response to high doses of citalopram in treatment-resistant obsessive-compulsive disorder
3. Refining treatment approaches in obsessive-compulsive disorder
4. Efficacy of fluvoxamine in obsessive compulsive disorder
5. The Yale-Brown Obsessive Compulsive Scale, I: Development, use and reliability
6. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder
7. A rating scale for depression
8. Counting the cost - The psychosocial and economic burden of OCD
9. The epidemiology of obsessive-compulsive disorder in five US Communities
10. Citalopram is effective in obsessive-compulsive disorder: Results of a double-blind, placebo controlled trial
11. Citalopram in the treatment of obsessive-compulsive disorder: An open pilot study
12. Obsessive-Compulsive Disorder: Familial-developmental history, symptomatology, comorbidity and course with special reference to gender-related pathogenetic differences
13. Peripheral markers of serotonin and dopamine function in obsessive-compulsive disorder
14. Update on pharmacologic management of OCD: Agents and augmentation
15. Combination pharmacological treatment strategies
16. Haloperidol addition in fluvoxamine-refractory obsessive compulsive disorder
17. Pharmacological treatment of obsessive-compulsive disorder
18. The SSRI citalopram is effective in the treatment of obsessive-compulsive disorder; results from a double-blind, fixed-dose, placebo-controlled trial
19. Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive compulsive disorder
20. Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: A single-blind study
21. Citalopram for treatment-resistant obsessive-compulsive disorder
22. Efficacy of drug treatment in obsessive-compulsive disorder
23. Beyond depression: Citalopram for obsessive-compulsive disorder
24. Therapeutic effect and safety of adjunctive risperidone in refractory obsessive-compulsive disorder (OCD)
25. Use of the selective serotonin reuptake inhibitor citalopram in a possible animal analogue of obsessive-compulsive disorder
26. Citalopram in obsessive-compulsive disorder: Key results of a double-blind trial
27. Child and adolescent obsessive-compulsive disorder treated with citalopram: Findings from an open trial of 23 cases
28. A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder
29. Obsessive-compulsive disorder: Psychobiological approaches to diagnosis, treatment and pathophysiology